Skip to main content
. 2020 Mar 26;267(7):2029–2041. doi: 10.1007/s00415-020-09777-5

Table 1.

IncobotulinumtoxinA doses administered, treatment patterns and injected muscles in the MP and OLEX

Units (high dose, 400 U) Units (low dose, 250 U) mLa Number of injection sitesa
MP: Upper-limb treatment, with treatment of thumb-in-palm
 Flexed wrist 100 62.50 2.0
  Flexor carpi radialisb 50 31.25 1.0 1–2
  Flexor carpi ulnarisb 50 31.25 1.0 1–2
 Clenched fist 100 62.50 2.0
  Flexor digitorum superficialisb 50 31.25 1.0 1–2
  Flexor digitorum profundusb 50 31.25 1.0 1–2
 Flexed elbow and pronated forearm 150 93.75 3.0
  Bicepsb 100 62.50 2.0 2–4
  Pronator teresb 50 31.25 1.0 1–2
 Thumb-in-palm 50 31.25 1.0
  Flexor pollicis longusb 20 12.50 0.4 1
  Adductor pollicisb 20 12.50 0.4 1
  Flexor pollicis brevis or opponens pollicisb 10 6.25 0.2 1
MP: Upper-limb treatment, without treatment of thumb-in-palm
 Flexed wrist 100 62.50 2.0
  Flexor carpi radialisb 50 31.25 1.0 1–2
  Flexor carpi ulnarisb 50 31.25 1.0 1–2
 Clenched fist 100 62.50 2.0
  Flexor digitorum superficialisb 50 31.25 1.0 1–2
  Flexor digitorum profundusb 50 31.25 1.0 1–2
 Flexed elbow and pronated forearm 200 125.00 4.0
  Bicepsb 100 62.50 2.0 2–4
  Brachialisb 50 31.25 1.0 1–2
  Pronator teresb 50 31.25 1.0 1–2
OLEX: Upper-limb treatment Unitsc mLc Number of injection sitesa
Flexed wrist
 Flexor carpi radialisd 25–100 0.5–2.0 1–2
 Flexor carpi ulnarisd 20–100 0.4–2.0 1–2
Clenched fist
 Flexor digitorum superficialisd 25–100 0.5–2.0 1–2
 Flexor digitorum profundusd 25–100 0.5–2.0 1–2
Flexed elbow and pronated forearm
 Brachioradialisd 25–100 0.5–2.0 1–3
 Bicepsd 50–200 1.0–4.0 2–4
 Brachialisd 25–100 0.5–2.0 1–2
 Pronator quadratusd 10–50 0.2–1.0 1
 Pronator teresd 25–75 0.5–1.5 1–2
If thumb spasticity is presentc
 Flexor pollicis longus 10–50 0.2–1.0 1
 Adductor pollicis 5–30 0.1–0.6 1
 Flexor pollicis brevis or opponens pollicis 5–30 0.1–0.6 1

MP main period; OLEX open-label extension

aMaximum 1.0 mL per injection site

bInjection of all these muscles is mandatory

cIf muscle is chosen for injection. For muscles not requiring treatment, 0 U/mL might be applicable

d400 U dose distribution at the investigator’s discretion